Actively Recruiting
Study of MRI Added to CT Scans to Better Select Pancreatic Cancer Patients for Surgery
Led by University of Aarhus · Updated on 2026-04-29
200
Participants Needed
3
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the added benefit of using magnetic resonance imaging MRI alongside computed tomography CT in diagnosing pancreatic cancer. This nationwide, prospective clinical trial aims to determine if MRI can better identify liver metastases in patients with pancreatic cancer to improve selection for surgery. The study is sponsored by the University of Aarhus and focuses on patients with locally resectable or borderline resectable tumors without liver metastases on CT. Participants will receive a preoperative MRI after their outpatient visit at the surgical clinic and before the scheduled surgery date. This diagnostic test is being evaluated to see if it changes treatment decisions compared to using CT alone. The study monitors patients through various timepoints including 1 week for treatment strategy changes and up to 3 years for survival and recurrence outcomes. During the study, participants undergo the MRI scan and are followed by researchers who assess treatment plans, surgical outcomes, survival rates, and healthcare costs. Key measurements include detection of liver metastases, surgery and resection rates within 1 month, and overall survival at 1 and 3 years. The total follow-up period extends to 3 years to track recurrence-free survival and long-term effects.
CONDITIONS
Brief Title
Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery
Research Team
J
Jakob Kirkegård, MD, PhD
F
Frank Mortensen, MD, DMSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here